Lung Cancer
Content writer – Clinical
August 16, 2023
Summary "Easy-to-find irAEs can be used as indicators to predict neoadjuvant chemo-immunotherapy response."
Lung cancer is the prominent cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) patients are diagnosed with early-stage disease in only 25% of cases, making them amenable to...
Content writer – Clinical
August 02, 2022
Summary "The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study."
Lung cancer is the leading cause of cancer-related death. The most frequent forms of treatment for lung cancer include chemotherapy, radiotherapy, and surgery. The most common type of lung cancer is...
Content writer – Clinical
July 12, 2023
Summary "Lung cancer prediction using robust machine learning and image enhancement methods on extracted gray-level co-occurrence matrix features."
In the present era, cancer is the leading cause of demise in both men and women world-wide, with low survival rates due to inefficient diagnostic techniques. In the year 2021, about 1,898,160 new cancer cases were...
Sr. scientist – Omics
July 05, 2023
Summary "Nivolumab therapy in addition to chemotherapy improves survival in patients with resectable lung cancer."
Lung cancer is the third most common cancer in the United States. Over 80% of the total lung cancer cases belong to the type of non-small cell lung cancer (NSCLC). Among the patients diagnosed with.
Sr. scientist – Omics
June 21, 2023
Summary "Role of air pollutants in lung cancer."
Lung cancer in never-smokers (LCINS) is the eighth most common cause of cancer death in the UK. Such patients bear distinct clinical and molecular characteristics compared to lung cancer in smokers which...
